Browsing Harvard Medical School by Keyword "Access to medicines"
Now showing items 1-3 of 3
-
Patient access schemes in Asia-pacific markets: current experience and future potential
(BioMed Central, 2015)Objectives: Patient access (or risk-sharing) schemes are alternative market access agreements between healthcare payers and medical product manufacturers for conditional coverage of promising health technologies. This study ... -
Stakeholders’ perspectives on access-to-medicines policy and research priorities in Latin America and the Caribbean: face-to-face and web-based interviews
(BioMed Central, 2014)Background: This study aims to rank policy concerns and policy-related research issues in order to identify policy and research gaps on access to medicines (ATM) in low- and middle-income countries in Latin America and the ... -
Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand
(BioMed Central, 2015)Objectives: New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: ...